Showing results (151-160 of 179) with videos related to
Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid TumorsAlbiruni R Abdul Razak, Morten Mau-Soerensen, Nashat Y Gabrail, et al.JCO Precision Oncology|November 15, 2021
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort ExperienceJennifer J Gile, Fang-Shu Ou, Amit Mahipal, et al.Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.Annals of Surgical Oncology|November 1, 2021
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerRoberto Alva-Ruiz, Lavanya Yohanathan, Jennifer A Yonkus, et al.Cancers|July 13, 2024
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal CancerConor D J O'Donnell, Nikolas Naleid, Teerada Siripoon, et al.JAMA Oncology|October 22, 2020
Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysisMohamad Bassam Sonbol, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic <i>BRAF</i>-Mutant MelanomaJean-Pierre Delord, Caroline Robert, Marta Nyakas, et al.The Oncologist|February 27, 2023
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020Nirosha D Perera, Tiffany R Bellomo, Walker M Schmidt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 StudyPhilip A Philip, Vaibhav Sahai, Nathan Bahary, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion CohortLaura Q M Chow, Robert Haddad, Shilpa Gupta, et al.Pageof 18